Showing results (91-100 of 156) with videos related to
Sort By:
Pageof 16
Journal of Occupational and Environmental Medicine|July 12, 2003
Paraoxonase in Persian Gulf War veteransMatthew Hotopf, Michael Ian Mackness, Vasilis Nikolaou, et al.Diabetes, Obesity & Metabolism|May 27, 2026
A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study DesignAndriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, et al.Science Translational Medicine|August 11, 2017
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetesMohammad Alhadj Ali, Yuk-Fun Liu, Sefina Arif, et al.Diabetes|October 7, 2008
Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex captureJennifer S Allen, Karl Pang, Ania Skowera, et al.Diabetologia|October 28, 2016
Immunogenicity of human embryonic stem cell-derived beta cellsCornelis R van der Torren, Arnaud Zaldumbide, Gaby Duinkerken, et al.Transplantation|January 16, 2004
The development of new density gradient media for purifying human islets and islet-quality assessmentsGuo Cai Huang, Min Zhao, Peter Jones, et al.Diabetes|October 4, 2013
Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetesMenno van Lummel, Gaby Duinkerken, Peter A van Veelen, et al.Diabetologia|April 6, 2020
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cellsSefina Arif, Iria Gomez-Tourino, Yogesh Kamra, et al.Diabetes|January 19, 2018
Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 DiabetesDeborah Kronenberg-Versteeg, Martin Eichmann, Mark A Russell, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
Effector-memory T cells develop in islets and report islet pathology in type 1 diabetesJonathan Chee, Hyun-Ja Ko, Ania Skowera, et al.Pageof 16